These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10508631)

  • 1. Engineering the mouse genome by site-specific recombination.
    Metzger D; Feil R
    Curr Opin Biotechnol; 1999 Oct; 10(5):470-6. PubMed ID: 10508631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering chromosomal rearrangements in mice.
    Yu Y; Bradley A
    Nat Rev Genet; 2001 Oct; 2(10):780-90. PubMed ID: 11584294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Cre"-ating mouse mutants-a meeting review on conditional mouse genetics.
    Rossant J; McMahon A
    Genes Dev; 1999 Jan; 13(2):142-5. PubMed ID: 9925637
    [No Abstract]   [Full Text] [Related]  

  • 4. Engineering adenovirus genome by bacterial artificial chromosome (BAC) technology.
    Ruzsics Z; Lemnitzer F; Thirion C
    Methods Mol Biol; 2014; 1089():143-58. PubMed ID: 24132484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering mouse chromosomes with Cre-loxP: range, efficiency, and somatic applications.
    Zheng B; Sage M; Sheppeard EA; Jurecic V; Bradley A
    Mol Cell Biol; 2000 Jan; 20(2):648-55. PubMed ID: 10611243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When reverse genetics meets physiology: the use of site-specific recombinases in mice.
    Tronche F; Casanova E; Turiault M; Sahly I; Kellendonk C
    FEBS Lett; 2002 Oct; 529(1):116-21. PubMed ID: 12354622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering embryonic stem cells with recombinase systems.
    Schnütgen F; Stewart AF; von Melchner H; Anastassiadis K
    Methods Enzymol; 2006; 420():100-36. PubMed ID: 17161696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome engineering: the new mouse genetics.
    Rossant J; Nagy A
    Nat Med; 1995 Jun; 1(6):592-4. PubMed ID: 7585128
    [No Abstract]   [Full Text] [Related]  

  • 9. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP.
    Rodríguez CI; Buchholz F; Galloway J; Sequerra R; Kasper J; Ayala R; Stewart AF; Dymecki SM
    Nat Genet; 2000 Jun; 25(2):139-40. PubMed ID: 10835623
    [No Abstract]   [Full Text] [Related]  

  • 10. Conditional mutagenesis in mice: the Cre/loxP recombination system.
    Plück A
    Int J Exp Pathol; 1996 Dec; 77(6):269-78. PubMed ID: 9155661
    [No Abstract]   [Full Text] [Related]  

  • 11. SIRT combines homologous recombination, site-specific integration, and bacterial recombineering for targeted mutagenesis in Drosophila.
    Gao G; Wesolowska N; Rong YS
    Cold Spring Harb Protoc; 2009 Jun; 2009(6):pdb.prot5236. PubMed ID: 20147194
    [No Abstract]   [Full Text] [Related]  

  • 12. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse.
    Brocard J; Warot X; Wendling O; Messaddeq N; Vonesch JL; Chambon P; Metzger D
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14559-63. PubMed ID: 9405652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double pronuclei injection of DNA into zygotes increases yields of transgenic mouse lines.
    Kupriyanov S; Zeh K; Baribault H
    Transgenic Res; 1998 May; 7(3):223-6. PubMed ID: 10461393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific chromosomal integration in mammalian cells: highly efficient CRE recombinase-mediated cassette exchange.
    Feng YQ; Seibler J; Alami R; Eisen A; Westerman KA; Leboulch P; Fiering S; Bouhassira EE
    J Mol Biol; 1999 Oct; 292(4):779-85. PubMed ID: 10525404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase.
    Nkrumah LJ; Muhle RA; Moura PA; Ghosh P; Hatfull GF; Jacobs WR; Fidock DA
    Nat Methods; 2006 Aug; 3(8):615-21. PubMed ID: 16862136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond 'knock-out' mice: new perspectives for the programmed modification of the mammalian genome.
    Cohen-Tannoudji M; Babinet C
    Mol Hum Reprod; 1998 Oct; 4(10):929-38. PubMed ID: 9809673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-efficiency Cre/loxP-based system for construction of adenoviral vectors.
    Ng P; Parks RJ; Cummings DT; Evelegh CM; Sankar U; Graham FL
    Hum Gene Ther; 1999 Nov; 10(16):2667-72. PubMed ID: 10566894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis.
    Zhang M; Kirsch DG
    Dis Model Mech; 2015 Sep; 8(9):1155-66. PubMed ID: 26183214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene targeting in the mouse: advances in introduction of transgenes into the genome by homologous recombination.
    Misra RP; Duncan SA
    Endocrine; 2002 Dec; 19(3):229-38. PubMed ID: 12624422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage integrases for the construction and manipulation of transgenic mammals.
    Hollis RP; Stoll SM; Sclimenti CR; Lin J; Chen-Tsai Y; Calos MP
    Reprod Biol Endocrinol; 2003 Nov; 1():79. PubMed ID: 14613545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.